A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.
about
Concerns about immunisationRevaccination against measles and rubellaBupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement NetworkA case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodologyEnhancing vaccine safety capacity globally: A lifecycle perspectiveUse of self-controlled designs in pharmacoepidemiologyChildhood immune thrombocytopenia: Clinical presentation and managementStatin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006Safety of pandemic (H1N1) 2009 monovalent vaccines in taiwan: a self-controlled case series study.Writing a Research Proposal to The Research Council of OmanA retrospective population-based study on seizures related to childhood vaccination.Idiopathic thrombocytopenic purpura and MMR vaccineOral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysisAdverse events following 12 and 18 month vaccinations: a population-based, self-controlled case series analysisFever following immunization.Prevention. How much harm? How much benefit? 1. Influence of reporting methods on perception of benefits.Prevalence of SCN1A-related dravet syndrome among children reported with seizures following vaccination: a population-based ten-year cohort studyAssociation between birth order and emergency room visits and acute hospital admissions following pediatric vaccination: a self-controlled studyEmerging vaccine informatics.Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines.MMR vaccine--worries are not justified.Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease?Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death.Evaluation of the Intussusception Risk after Pentavalent Rotavirus Vaccination in Finnish InfantsMMR: where are we now?The use of relative incidence ratios in self-controlled case series studies: an overview.Use of the self-controlled case series method in drug safety assessmentSelf-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic reviewSurveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012Feasibility study for identifying adverse events attributable to vaccination by record linkageFactors associated with mumps meningitis and the possible impact of vaccination.Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionalsPost-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions.Annual report on adverse events related with vaccines use in Calabria (Italy): 2012.Association between socioeconomic status and adverse events following immunization at 2, 4, 6 and 12 months.Surveillance of adverse effects following vaccination and safety of immunization programs.Vaccinations and febrile seizures.Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice.Vaccines and febrile seizures.Pharmacoepidemiological assessment of drug interactions with vitamin K antagonists.
P2860
Q24524552-8BCC3CE1-9D72-40EA-8F73-316D328D792FQ24655540-D1C51572-EA66-4FF4-986D-74AA00D01E82Q24678592-30F5F2F1-ACE2-4FF0-8D3E-6B7354101E3DQ24796478-84395525-06B6-4BE4-83A5-B79B1BD01609Q26782451-CE28F3FC-87A9-48D2-8DF5-4DEA434E3358Q26822935-2CD785E2-1BF6-43E7-A723-F4412A5F7431Q27023294-F4CE1614-8C11-4135-9899-FA189222FC0FQ28473021-5BCC8B73-86F0-4F10-9709-5B49D056B761Q30428839-0E1309FF-E496-43A1-98DD-65F23969F5B4Q30491909-A5520411-9E3E-4AB3-A372-FE6EBBC65433Q33160174-2664861F-6375-47AF-8F43-6D913E090142Q33336096-4101CD28-A183-4763-92D4-B1451314B681Q33415484-DC4EBA93-7B1D-415B-AE52-2154E534DD2AQ34102900-F617ED1E-9DDB-4669-AD59-711C8E3995F7Q34434824-0800D8C2-CAB8-4A55-9ADD-96ADBFD82891Q34712222-E09445A2-3FC6-4D28-B7CE-981B07E24AAAQ34770167-D44F0475-1C95-4E21-A9BF-DE78CA27C681Q35063868-614B82A6-4AB2-4897-B3F6-458B773FC9D3Q35100809-B3454F34-A8C3-4671-AC3D-40DD54D00185Q35193529-D7CE3A39-762B-4AE5-B34D-CD31FA8DC8B8Q35271392-EB72D79D-BFDF-4222-BE64-F835D47A56EDQ35535459-63C56173-2A12-4C2A-8FD4-28544088014DQ35539575-88D9D16F-5E2D-40FF-8080-2FDA1CE8F322Q35947992-30490921-7B4E-4C1C-8C4D-D68B2D0FB48CQ36121506-23BB6A8E-0868-4EF3-A195-53D268192600Q36143663-BA1DEFBE-4343-47B2-BA5A-02B81860B19BQ36204221-E9F6C901-77F3-4C6A-A7EA-363CC9B3529EQ36274482-658649E8-C341-4E18-AED3-23FD8436F0F7Q36478305-1E0D2C08-163D-4D1C-BAC7-F843A5AA0004Q36503631-89554BE6-8C88-4125-8137-C4A82963493DQ36578928-00865F33-81A2-43F6-9E13-D51F816652DAQ37137964-D1012165-D9F1-4D15-B370-6F2ACB9E07C9Q37142453-B911AA66-58C1-48EA-A841-CCDCC778A4C0Q37369663-CCDF5EF2-9BF8-4C38-8C78-2189D6F03A10Q37505429-AEEEA709-8CCA-4807-8E23-3CC62AD62332Q37823382-BF4D8B72-2E24-4617-9A6A-C75C9D1D40EAQ37872028-B3604E6E-42BF-4811-8911-A224B5CA13C9Q37919183-66491CAB-3215-4E9B-9A06-1E04CF21FE39Q38132266-48A0F353-92E5-4012-A715-D0C8FF063C7BQ38253820-EB33641F-5F22-4148-A8C7-4D5E06FB3002
P2860
A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
A new method for active survei ...... easles/mumps/rubella vaccines.
@ast
A new method for active survei ...... easles/mumps/rubella vaccines.
@en
type
label
A new method for active survei ...... easles/mumps/rubella vaccines.
@ast
A new method for active survei ...... easles/mumps/rubella vaccines.
@en
prefLabel
A new method for active survei ...... easles/mumps/rubella vaccines.
@ast
A new method for active survei ...... easles/mumps/rubella vaccines.
@en
P2093
P1433
P1476
A new method for active survei ...... easles/mumps/rubella vaccines.
@en
P2093
A Colville
P Farrington
P Morgan-Capner
P304
P356
10.1016/S0140-6736(95)90471-9
P407
P577
1995-03-01T00:00:00Z